Treatment of Hydrosalpinx before IVF-ET

AN Jin-xia; GAO Xi-hong

Abstract：Hydrosalpinx can reduce the pregnancy rate and implantation rate of in vitro fertilization and embryo transfer (IVF-ET), and increase the rate of spontaneous abortion. Hydrosalpinx may affect the IVF-ET clinical outcome by embryo toxicity, impairment of endometrial receptivity, mechanical hindrance to implantation. At present, the treatment options of hydrosalpinx are multifarious, including salpingectomy, salpingostomy, tubal ligation, tubal occlusion by hysteroscopy, transvaginal aspiration of fluid, and combination of Chinese and Western Medicine. Salpingectomy may affect ovarion response in IVF hyperstimulation. As for transvaginal aspiration of fluid, although there are smiple and less invasive advantages, the recurrence rate is high. The Essure?and Adiana?microimplant by hysteroscopy for tubal occlusion are trying to treat hydrosalpinx in clinical practice in recent years. The efficiency, advantage and disadvantage of different treatment schemes of hydrosalpinx were compared in this review, which is helpful for clinical doctors to select better individualized strategies before assisted reproductive technology(ART) treatment for those patients with hydrosalpinx.